These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 21849887)
1. Antitumor effects of the benzophenanthridine alkaloid sanguinarine in a rat syngeneic model of colorectal cancer. Pica F; Balestrieri E; Serafino A; Sorrentino R; Gaziano R; Moroni G; Moroni N; Palmieri G; Mattei M; Garaci E; Sinibaldi-Vallebona P Anticancer Drugs; 2012 Jan; 23(1):32-42. PubMed ID: 21849887 [TBL] [Abstract][Full Text] [Related]
2. Sanguinarine induces apoptosis in A549 human lung cancer cells primarily via cellular glutathione depletion. Jang BC; Park JG; Song DK; Baek WK; Yoo SK; Jung KH; Park GY; Lee TY; Suh SI Toxicol In Vitro; 2009 Mar; 23(2):281-7. PubMed ID: 19135517 [TBL] [Abstract][Full Text] [Related]
3. Sanguinarine induces apoptosis of human pancreatic carcinoma AsPC-1 and BxPC-3 cells via modulations in Bcl-2 family proteins. Ahsan H; Reagan-Shaw S; Breur J; Ahmad N Cancer Lett; 2007 May; 249(2):198-208. PubMed ID: 17005319 [TBL] [Abstract][Full Text] [Related]
4. Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma. De Stefano I; Raspaglio G; Zannoni GF; Travaglia D; Prisco MG; Mosca M; Ferlini C; Scambia G; Gallo D Biochem Pharmacol; 2009 Dec; 78(11):1374-81. PubMed ID: 19643088 [TBL] [Abstract][Full Text] [Related]
5. Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition. Kalogris C; Garulli C; Pietrella L; Gambini V; Pucciarelli S; Lucci C; Tilio M; Zabaleta ME; Bartolacci C; Andreani C; Giangrossi M; Iezzi M; Belletti B; Marchini C; Amici A Biochem Pharmacol; 2014 Aug; 90(3):226-34. PubMed ID: 24875448 [TBL] [Abstract][Full Text] [Related]
6. The effect of chelerythrine on cell growth, apoptosis, and cell cycle in human normal and cancer cells in comparison with sanguinarine. Malíková J; Zdarilová A; Hlobilková A; Ulrichová J Cell Biol Toxicol; 2006 Nov; 22(6):439-53. PubMed ID: 16964588 [TBL] [Abstract][Full Text] [Related]
8. Sanguinarine overcomes P-glycoprotein-mediated multidrug-resistance via induction of apoptosis and oncosis in CEM-VLB 1000 cells. Weerasinghe P; Hallock S; Tang SC; Trump B; Liepins A Exp Toxicol Pathol; 2006 Aug; 58(1):21-30. PubMed ID: 16735106 [TBL] [Abstract][Full Text] [Related]
9. Sanguinarine sensitizes human gastric adenocarcinoma AGS cells to TRAIL-mediated apoptosis via down-regulation of AKT and activation of caspase-3. Choi WY; Jin CY; Han MH; Kim GY; Kim ND; Lee WH; Kim SK; Choi YH Anticancer Res; 2009 Nov; 29(11):4457-65. PubMed ID: 20032392 [TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis. Pourgholami MH; Akhter J; Wang L; Lu Y; Morris DL Cancer Chemother Pharmacol; 2005 May; 55(5):425-32. PubMed ID: 15565325 [TBL] [Abstract][Full Text] [Related]
11. Sanguinarine inhibits growth of human cervical cancer cells through the induction of apoptosis. Xu JY; Meng QH; Chong Y; Jiao Y; Zhao L; Rosen EM; Fan S Oncol Rep; 2012 Dec; 28(6):2264-70. PubMed ID: 22965493 [TBL] [Abstract][Full Text] [Related]
12. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer. Wang L; Chen W; Xie X; He Y; Bai X Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340 [TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft models. Ferguson D; Rodriguez LE; Palma JP; Refici M; Jarvis K; O'Connor J; Sullivan GM; Frost D; Marsh K; Bauch J; Zhang H; Lin NH; Rosenberg S; Sham HL; Joseph IB Clin Cancer Res; 2005 Apr; 11(8):3045-54. PubMed ID: 15837760 [TBL] [Abstract][Full Text] [Related]
15. Rapamycin inhibits hepatectomy-induced stimulation of metastatic tumor growth by reduction of angiogenesis, microvascular blood perfusion, and tumor cell proliferation. Rupertus K; Dahlem C; Menger MD; Schilling MK; Kollmar O Ann Surg Oncol; 2009 Sep; 16(9):2629-37. PubMed ID: 19551445 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of somatostatin analogue RC-160 on the growth of hepatic metastases of colon cancer in rats: a study with magnetic resonance imaging. Qin Y; Van Cauteren M; Osteaux M; Schally AV; Willems G Cancer Res; 1992 Nov; 52(21):6025-30. PubMed ID: 1356623 [TBL] [Abstract][Full Text] [Related]
17. Sanguinarine causes DNA damage and p53-independent cell death in human colon cancer cell lines. Matkar SS; Wrischnik LA; Hellmann-Blumberg U Chem Biol Interact; 2008 Mar; 172(1):63-71. PubMed ID: 18243168 [TBL] [Abstract][Full Text] [Related]
18. Sanguinarine induces apoptosis in human colorectal cancer HCT-116 cells through ROS-mediated Egr-1 activation and mitochondrial dysfunction. Han MH; Kim GY; Yoo YH; Choi YH Toxicol Lett; 2013 Jul; 220(2):157-66. PubMed ID: 23660334 [TBL] [Abstract][Full Text] [Related]
19. Anti-invasive activity of sanguinarine through modulation of tight junctions and matrix metalloproteinase activities in MDA-MB-231 human breast carcinoma cells. Choi YH; Choi WY; Hong SH; Kim SO; Kim GY; Lee WH; Yoo YH Chem Biol Interact; 2009 May; 179(2-3):185-91. PubMed ID: 19063874 [TBL] [Abstract][Full Text] [Related]
20. Sanguinarine triggers intrinsic apoptosis to suppress colorectal cancer growth through disassociation between STRAP and MELK. Gong X; Chen Z; Han Q; Chen C; Jing L; Liu Y; Zhao L; Yao X; Sun X BMC Cancer; 2018 May; 18(1):578. PubMed ID: 29783958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]